Regulatory Writing : an Imperative Step of your Clinical Research
A clinical development program's success or failure is determined by the effective documentation of research plans and results
ADI provides a comprehensive range of regulatory writing services encompassing all clinical phases and critical therapeutic areas. From writing to publishing standards, ADI has significant expertise in delivering quality projects within a valuable timeline. Our writers' continuing training programme keeps them up to date on industry norms and produces papers with the 4 C’s, i.e., clear, concise, consistent, and complete.
We Compile, Organize, Write, and Publicize a wide range of High-Quality Regulatory and Safety Documents that include:
The ICH GCP-compliant protocols ensure progress in the clinical phase of drug development. Our specialists can help with
Magnify the impact of CSR and increase the chances of FDA approval We formulate fully optimized and well-organized CSRs for the finest written CTDs We provide
The IND is the FDA's first step in approving clinical trials. This initial trial step, along with the subsequent trial documentation takes considerable time and effort to ensure consistency among documents and make the overall conclusions clear We offer
Our SOP solution approach is to develop bespoke plans for your clinical operations monitoring feasibility and project management allowing us to pinpoint the critical areas We create SOPs for
Our clinical data handlers utilize their knowledge to produce clear and concise ICFs that cover all the essential elements of a protocol/study We develop ICFs that consist
Narratives add momentum to the current state of development allowing clients to provide better diagnoses and devise better solutions The issues extracted as a patient narrative draw considerable meaningful insight We write narratives that